https://www.selleckchem.com/products/fgf401.html
0% (95% CI 96.2-99.0% (442/451)) of children tested one month after single-dose immunization, in 93.5% (95% CI 91.0-95.4% (477/51) and in 91.1% (95% CI 88.2-93.4% (422/463)) of children one year and five years after single-dose immunization, respectively. Anti-HAV antibody geometric mean concentrations were similar in sera collected one month, one year, and five years following single-dose vaccination 40.24 mIU/mL, 44.96 mIU/mL, and 57.73 mIU/mL, respectively (p 0.05). These data confirm that single-dose vaccination is an effectiv